Found 7 matching trials
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation PHASE2 Background:
Blood stem cells in the bone marrow make all the cells to norm...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide PHASE2 This is a prospective, multi-center, Phase II study of hematopoietic cell t...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical Center
Learn More & Join Trial
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation PHASE2 The purpose of this clinical trial is to compare drug combinations to learn...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide PHASE2 This is a multi-center, single arm Phase II study of hematopoietic cell tra...
Show More Location
Shands HealthCare & University of Florida
Learn More & Join Trial
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source PHASE1 The purpose of this study is to determine whether stem cells collected from...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. PHASE2 A phase II trial of a reduced intensity conditioned (RIC) allogeneic hemato...
Show More Location
University of Minnesota Masonic Cancer Center
Learn More & Join Trial
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis PHASE2 The goal of this clinical trial is to determine the effectiveness of Reduce...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Learn More & Join Trial